{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T14:50:33Z","timestamp":1777992633123,"version":"3.51.4"},"reference-count":30,"publisher":"JLE","issue":"6","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.nephro.2017.11.002","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T21:35:39Z","timestamp":1515188139000},"page":"462-466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["D\u00e9pistage de la n\u00e9phropathie dans les syndromes dr\u00e9panocytaires majeurs chez les patients suivis au Centre national de r\u00e9f\u00e9rence de la dr\u00e9panocytose de Niamey, Niger"],"prefix":"10.1684","volume":"14","author":[{"given":"Moumouni","family":"Garba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeinabou Maiga","family":"Moussa Tondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Diongoule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samaila","family":"Aboubacar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdou","family":"Ide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nad\u00e8ge Ruddy","family":"Biyao-Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Illiassou","family":"Soumaila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumana","family":"Alido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2017.11.002_bib0155","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2017.11.002_bib0160","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1056\/NEJM199204023261402","article-title":"Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme","volume":"326","author":"Falk","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2017.11.002_bib0165","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/pmj.79.933.384","article-title":"Pulmonary manifestations of sickle cell disease","volume":"79","author":"Siddiqui","year":"2003","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.nephro.2017.11.002_bib0170","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1093\/ndt\/gfq186","article-title":"Could sickle cell trait be a predisposing risk factor for CKD?","volume":"25","author":"Shaw","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2017.11.002_bib0175","doi-asserted-by":"crossref","DOI":"10.1038\/nrneph.2015.8","article-title":"Sickle cell disease: renal manifestations and mechanisms","author":"Nath","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.nephro.2017.11.002_bib0180","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2017.11.002_bib0185","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/bjh.12024","article-title":"High one year mortality in adults with sickle cell disease and end-stage renal disease","volume":"159","author":"McClellan","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.nephro.2017.11.002_bib0190","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1001\/jama.289.13.1645","article-title":"Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: Risks and benefits up to 9\u00a0years of treatment","volume":"289","author":"Steinberg","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.nephro.2017.11.002_bib0195","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1053\/j.ajkd.2003.12.046","article-title":"Unreferred chronic kidney disease: a longitudinal study","volume":"43","author":"John","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2017.11.002_bib0200","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1681\/ASN.2002010084","article-title":"Glomerular involvement in adults with sickle cell hemoglobinopathies: prevalence and clinical correlates of progressive renal failure","volume":"17","author":"Guasch","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2017.11.002_bib0205","first-page":"1","article-title":"KDIGO 2012\u00a0clinical practice guideline for the evaluation and management of chronic kidney Disease","volume":"3","year":"2013","journal-title":"Kidney inter Suppl"},{"key":"10.1016\/j.nephro.2017.11.002_bib0210","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2369-13-83","article-title":"Determination of the best method to estimate glomerular filtration rate from serum creatinine in adult patients with sickle cell disease: a prospective observational cohort study","author":"Arlet","year":"2012","journal-title":"BMC Nephrology"},{"key":"10.1016\/j.nephro.2017.11.002_bib0215","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2017.11.002_bib0220","doi-asserted-by":"crossref","first-page":"756","DOI":"10.2215\/CJN.08511109","article-title":"Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated feature","volume":"5","author":"Haymann","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2017.11.002_bib0225","first-page":"7","article-title":"Chronic kidney disease: sickle cell nephropathy as a likely cause","volume":"4","author":"Kadiri","year":"2006","journal-title":"Ann Ibadan Postgrad Med"},{"key":"10.1016\/j.nephro.2017.11.002_bib0230","doi-asserted-by":"crossref","first-page":"349","DOI":"10.5581\/1516-8484.20130107","article-title":"Glomerular fltration rate is altered in children with sickle cell disease: a comparison between Hb SS and Hb SC","volume":"35","author":"de Paula","year":"2013","journal-title":"Rev Bras Hematol Hemoter"},{"key":"10.1016\/j.nephro.2017.11.002_bib0235","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ajh.23365","article-title":"Hydroxyurea treatment decreases glomerular hyperfltration in children with sickle cell anemia","volume":"88","author":"Aygun","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.nephro.2017.11.002_bib0240","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1681\/ASN.2014111126","article-title":"Six months of hydroxyurea reduces albuminuria in patients with sickle cell disease","volume":"27","author":"Bartolucci","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2017.11.002_bib0245","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/ndt\/gft295","article-title":"Hydroxyurea is associated with lower prevalence of albuminuria in adults with sickle cell disease","volume":"29","author":"Laurin","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2017.11.002_bib0250","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/MOH.0b013e328351c35f","article-title":"Clinical management of adult sickle-cell disease","volume":"19","author":"Bartolucci","year":"2012","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.nephro.2017.11.002_bib0255","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMct0708272","article-title":"Hydroxyurea for the treatment of sickle cell anemia","volume":"358","author":"Platt","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2017.11.002_bib0260","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.14724","article-title":"Clinical and genetic predictors of renal dysfunctions in sickle cell anaemia in Cameroon","author":"Geard","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.nephro.2017.11.002_bib0265","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00467-011-1857-2","article-title":"Glomerular hyperfiltration and albuminuria in children with sickle cell anemia","volume":"26","author":"Aygun","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nephro.2017.11.002_bib0270","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.2215\/CJN.01600211","article-title":"Chronic kidney disease and albuminuria in children with sickle cell disease","volume":"6","author":"McPherson Yee","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2017.11.002_bib0275","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-015-0072-y","article-title":"Chronic kidney disease is common in sickle cell disease: a cross-sectional study in the Tema Metropolis, Ghana","author":"Ephraim","year":"2015","journal-title":"BMC Nephrology"},{"key":"10.1016\/j.nephro.2017.11.002_bib0280","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/01.JIM.0000446836.75352.72","article-title":"Prevalence and progression of chronic kidney disease in adult patients with sickle cell disease","volume":"62","author":"Gosmanova","year":"2014","journal-title":"J Investig Med"},{"key":"10.1016\/j.nephro.2017.11.002_bib0285","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/ki.1996.109","article-title":"Early detection and the course of glomerular injury in patients with sickle cell anemia","volume":"49","author":"Guasch","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2017.11.002_bib0290","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/ajkd.1998.v32.pm9708603","article-title":"Early glomerular dysfunction in patients with sickle cell anemia","volume":"32","author":"Schmitt","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2017.11.002_bib0295","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ajh.20800","article-title":"Estimated glomerular filtration rate in sickle cell anemia is associated with polymorphisms of bone morphogenetic protein receptor\u00a01B","volume":"82","author":"Nolan","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.nephro.2017.11.002_bib0300","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.3324\/haematol.2016.154153","article-title":"APOL1, a-thalassemia, and BCL11A variants as a genetic risk profile for progression of chronic kidney disease in sickle cell anemia","volume":"102","author":"Saraf","year":"2017","journal-title":"Haematologica"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725517306065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725517306065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2017.11.002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:09:36Z","timestamp":1741190976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725517306065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1769725517306065"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2017.11.002","relation":{},"ISSN":["1769-7255"],"issn-type":[{"value":"1769-7255","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"D\u00e9pistage de la n\u00e9phropathie dans les syndromes dr\u00e9panocytaires majeurs chez les patients suivis au Centre national de r\u00e9f\u00e9rence de la dr\u00e9panocytose de Niamey, Niger","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2017.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Soci\u00e9t\u00e9 francophone de n\u00e9phrologie, dialyse et transplantation. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}